BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 31087796)

  • 1. Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses.
    Teede H; Tassone EC; Piltonen T; Malhotra J; Mol BW; Peña A; Witchel SF; Joham A; McAllister V; Romualdi D; Thondan M; Costello M; Misso ML
    Clin Endocrinol (Oxf); 2019 Oct; 91(4):479-489. PubMed ID: 31087796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.
    Fraison E; Kostova E; Moran LJ; Bilal S; Ee CC; Venetis C; Costello MF
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD005552. PubMed ID: 32794179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis.
    Melin J; Forslund M; Alesi S; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena A; Witchel SF; Mousa A; Teede H
    J Clin Endocrinol Metab; 2024 Jan; 109(2):e817-e836. PubMed ID: 37554096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
    Alesi S; Forslund M; Melin J; Romualdi D; Peña A; Tay CT; Witchel SF; Teede H; Mousa A
    EClinicalMedicine; 2023 Sep; 63():102162. PubMed ID: 37583655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: A systematic review.
    Forslund M; Melin J; Alesi S; Piltonen T; Romualdi D; Tay CT; Witchel S; Pena A; Mousa A; Teede H
    Clin Endocrinol (Oxf); 2023 Jul; 99(1):79-91. PubMed ID: 36939017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
    Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.
    Costello M; Shrestha B; Eden J; Sjoblom P; Johnson N
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005552. PubMed ID: 17253562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and surgical treatment of nonreproductive outcomes in polycystic ovary syndrome: An overview of systematic reviews.
    Tay CT; Joham AE; Hiam DS; Gadalla MA; Pundir J; Thangaratinam S; Teede HJ; Moran LJ
    Clin Endocrinol (Oxf); 2018 Nov; 89(5):535-553. PubMed ID: 29846959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials.
    Almalki HH; Alshibani TM; Alhifany AA; Almohammed OA
    BMC Womens Health; 2020 Apr; 20(1):68. PubMed ID: 32248801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis.
    Wang A; Mo T; Li Q; Shen C; Liu M
    Endocrine; 2019 May; 64(2):220-232. PubMed ID: 30911997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis.
    Forslund M; Melin J; Alesi S; Piltonen T; Romualdi D; Tay CT; Witchel S; Pena A; Mousa A; Teede H
    Eur J Endocrinol; 2023 Jul; 189(1):S1-S16. PubMed ID: 37440702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
    Zhao H; Xing C; Zhang J; He B
    Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 international evidence-based guideline.
    Goldberg A; Graca S; Liu J; Rao V; Witchel SF; Pena A; Li R; Mousa A; Tay CT; Pattuwage L; Teede H; Yildiz BO; Ee C
    Obes Rev; 2024 May; 25(5):e13704. PubMed ID: 38355887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
    Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins for women with polycystic ovary syndrome not actively trying to conceive.
    Raval AD; Hunter T; Stuckey B; Hart RJ
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008565. PubMed ID: 21975784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Melin J; Forslund M; Alesi S; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena A; Witchel SF; Mousa A; Teede H
    Eur J Endocrinol; 2023 Aug; 189(2):S37-S63. PubMed ID: 37536294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of oral contraceptive and metformin did not improve insulin resistance in women with polycystic ovary syndrome.
    Iwata MC; Porquere L; Sorpreso IC; Baracat EC; Soares Júnior JM
    Rev Assoc Med Bras (1992); 2015; 61(3):215-9. PubMed ID: 26248242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
    Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
    Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review.
    Costello MF; Shrestha B; Eden J; Johnson NP; Sjoblom P
    Hum Reprod; 2007 May; 22(5):1200-9. PubMed ID: 17261574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined oral contraceptives and/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis.
    Luque-Ramírez M; Nattero-Chávez L; Ortiz Flores AE; Escobar-Morreale HF
    Hum Reprod Update; 2018 Mar; 24(2):225-241. PubMed ID: 29293982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.